Lupkynis Interactions
There are 852 drugs known to interact with Lupkynis (voclosporin), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 426 are major, 415 are moderate, and 11 are minor.
- View all 852 medications that may interact with Lupkynis
- View Lupkynis alcohol/food interactions (2)
- View Lupkynis disease interactions (8)
Most frequently checked interactions
View interaction reports for Lupkynis (voclosporin) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Adynovate (antihemophilic factor)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- ambrisentan
- Amondys 45 (casimersen)
- apremilast
- Aubagio (teriflunomide)
- Augmentin (amoxicillin / clavulanate)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Emgality (galcanezumab)
- Farxiga (dapagliflozin)
- Gilotrif (afatinib)
- Jardiance (empagliflozin)
- Lipitor (atorvastatin)
- prednisone
Lupkynis alcohol/food interactions
There are 2 alcohol/food interactions with Lupkynis (voclosporin).
Lupkynis disease interactions
There are 8 disease interactions with Lupkynis (voclosporin) which include:
- infections
- liver dysfunction
- nephrotoxicity
- neurotoxicities
- PRCA
- QT prolongation
- vaccination
- Voclosporin – hypertension
More about Lupkynis (voclosporin)
- Lupkynis consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.